Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MB07803 in Patients With Type 2 Diabetes Mellitus
NCT00458016Phase 2Completed
- Sponsor
- Ligand Pharmaceuticals
- Start
- Mar 2007
- Primary completion
- Mar 2008
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of MB-07803 in type 2 diabetes mellitus (T2DM), sponsored by Ligand Pharmaceuticals. Started Mar 2007; status: completed.
02
Drugs
MB-07803
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00458016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00458016.